KCM
CLVS

Kingdon Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Kingdon Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,600
Closed -$29K – 89
2018
Q4 		$29K Sell
1,600
-390,359
-100% -$7.98M 0.01% 59
2018
Q3 		$11.5M Buy
391,959
+18,971
+5% +$734K 1.07% 48
2018
Q2 		$17M Buy
372,988
+156,964
+73% +$7.63M 1.46% 25
2018
Q1 		$11.4M Buy
216,024
+100,182
+86% +$5.85M 0.98% 41
2017
Q4 		$7.88M Sell
115,842
-40,120
-26% -$2.81M 0.69% 62
2017
Q3 		$12.9M Buy
155,962
+81,081
+108% +$6.43M 1.04% 41
2017
Q2 		$7.01M Buy
+74,881
New +$4.58M 0.6% 62
2015
Q4 		– Sell
-20,600
Closed -$1.89M – 181
2015
Q3 		$1.89M Buy
+20,600
New +$1.78M 0.15% 107

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return